NIH-funded research NIH-funded research

Understanding and overcoming barriers to malaria control in the Asia-Pacific

Official title: Understanding and Targeting the Barriers to Effective Malaria Control and Elimination in the Asia-Pacific Region

Funded at Walter and Eliza Hall Inst Medical Res · NIH-11516995 · Data updated 2026-11-12

A multi-site project tests new ways to track and reduce malaria in Cambodia, Papua New Guinea, and other Asia-Pacific areas to help communities move toward elimination.

More Malaria research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWalter and Eliza Hall Inst Medical Res
NIH-funded
Lab location1 site (Parkville, AUSTRALIA)
Project startApril 1, 2025
Project endMarch 31, 2029
Funding year2026
Award (this year)$272,708
NIH project number3U19AI129392-11S2
Project IDNIH-11516995 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include people living in malaria-endemic areas in Cambodia and PNG, especially those in communities with ongoing Pv or Pf transmission and those participating in surveillance activities.

Less likely to help

Individuals not connected to malaria-endemic areas or not participating in any surveillance or intervention activities may see no direct benefit.

What this research studies

This initiative brings fieldwork, lab work, and modeling to understanding why malaria remains a problem in some places and how best to use limited resources. Researchers will combine traditional disease surveillance with targeted surveys and innovative tools to identify where transmission happens and which interventions work best. The study will explore how asymptomatic infections, drug and insecticide resistance, and local transmission patterns affect control efforts. Findings could guide smarter allocation of effort and resources to reduce malaria transmission in diverse settings.

Why it matters

Potential benefit: If successful, the project could improve how malaria is detected, prevented, and interrupted in the Asia-Pacific, potentially speeding toward elimination and protecting communities.

How similar studies have gone: Previous ICEMR work in the region demonstrated varying malaria trends and informed targeted strategies, with ongoing potential for improvement through integrated approaches.

Where this research is happening

  • Walter and Eliza Hall Inst Medical Res
    Parkville, Australia
    Active

Researchers

  • Principal investigator: Mueller, Ivo J — Walter and Eliza Hall Inst Medical Res
  • Study coordinator: Mueller, Ivo J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.